Telbivudine
Telbivudine is a topic covered in the Johns Hopkins HIV Guide.
To view the entire topic, please sign in or purchase a subscription.
Official website of the Johns Hopkins Antibiotic (ABX), HIV, Diabetes, and Psychiatry Guides, powered by Unbound Medicine. Johns Hopkins Guide App for iOS, iPhone, iPad, and Android included. Explore these free sample topics:
-- The first section of this topic is shown below --
INDICATIONS
FDA
FDA
- Treatment of chronic hepatitis B (HBeAg-negative or -positive) with ongoing viral replication and evidence of transferase elevation or histologically active disease.
-- To view the remaining sections of this topic, please sign in or purchase a subscription --
Last updated: July 8, 2018
Citation
Smith, Janessa M, and Paul A Pham. "Telbivudine." Johns Hopkins HIV Guide, 2018. Johns Hopkins Guide, www.hopkinsguides.com/hopkins/view/Johns_Hopkins_HIV_Guide/545198/all/Telbivudine.
Smith JM, Pham PA. Telbivudine. Johns Hopkins HIV Guide. 2018. https://www.hopkinsguides.com/hopkins/view/Johns_Hopkins_HIV_Guide/545198/all/Telbivudine. Accessed August 19, 2019.
Smith, J. M., & Pham, P. A. (2018). Telbivudine. In Johns Hopkins HIV Guide. Available from https://www.hopkinsguides.com/hopkins/view/Johns_Hopkins_HIV_Guide/545198/all/Telbivudine
Smith JM, Pham PA. Telbivudine [Internet]. In: Johns Hopkins HIV Guide. ; 2018. [cited 2019 August 19]. Available from: https://www.hopkinsguides.com/hopkins/view/Johns_Hopkins_HIV_Guide/545198/all/Telbivudine.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Telbivudine
ID - 545198
A1 - Smith,Janessa,Pharm.D., BCPS
AU - Pham,Paul,Pharm.D.
Y1 - 2018/07/08/
BT - Johns Hopkins HIV Guide
UR - https://www.hopkinsguides.com/hopkins/view/Johns_Hopkins_HIV_Guide/545198/all/Telbivudine
DB - Johns Hopkins Guide
DP - Unbound Medicine
ER -